Check the

LARYNGOTECH LTD

Company
LARYNGOTECH LTD (06734675)

LARYNGOTECH

Phone: 01895 634 292
A⁺ rating

ABOUT LARYNGOTECH LTD

The Laryngotech Training Mannequin

About Laryngotech

Laryngotech is a company comprising of skilled medical professionals with over 20 years of surgical experience in the ENT field. We recognised several years ago that there was a very clear need for a multifunctional training tool which would allow ENT surgeons the opportunity to hone their surgical skills in a simulated environment with both the more traditional micro-instruments and with lasers.

The Laryngotech mannequins have been developed over several years of teaching ENT trainees in a theatre environment. Validation studies confirm its value as a simulator in improving surgical skills. The synthetic vocal cord inserts with different pathologies have a definite advantage over animal tissue.

The Laryngotech team has continued to develop its products via rigorous testing and through the provision of training seminars to NHS trusts in London, Brighton, Birmingham, Cardiff and Derby (amongst others) since 2009.

Interest has been shown in this product from Europe, the Far East and America. We are focused on continued research and development to ensure that Laryngotech are consistently providing the most innovative simulators for the teaching of medical trainees.

For further information regarding our products, training seminars and hire or purchase of the complete Laryngotech range please contact us

For further information regarding our products or training seminars please

Introducing Laryngotech

The company was formed in 2012. It’s aim is to create a training mannequin to give laryngologists and other ENT professionals the opportunity to hone their surgical skills on a realistic model in both theatre and the office/outpatient environment.

Laryngotech has developed anatomically detailed products with accurate pathology for the teaching and fine-tuning of advanced laser and micro-surgical skills and also to enable consultant-led training scenarios to improve leadership and teamwork.

Laryngotech is committed to innovation, adaptability and quality within the medical training field.

Please contact us for further information regarding our products and training seminars

KEY FINANCES

Year
2017
Assets
£7.16k ▼ £-3.17k (-30.69 %)
Cash
£0k ▼ £-7.97k (-100.00 %)
Liabilities
£7.16k ▼ £-0.84k (-10.45 %)
Net Worth
£0.01k ▼ £-2.34k (-99.70 %)

REGISTRATION INFO

Company name
LARYNGOTECH LTD
Company number
06734675
Status
Active
Categroy
Private Limited Company
Date of Incorporation
28 Oct 2008
Age - 16 years
Home Country
United Kingdom

CONTACTS

Website
www.laryngotech.com
Phones
01895 634 292
Registered Address
124 RYE HOUSE,
113 HIGH STREET RUISLIP,
MIDDLESEX,
HA4 8JN

ECONOMIC ACTIVITIES

86900
Other human health activities

LAST EVENTS

30 Oct 2016
Confirmation statement made on 28 October 2016 with updates
14 Sep 2016
Total exemption small company accounts made up to 31 March 2016
12 Nov 2015
Annual return made up to 28 October 2015 with full list of shareholders Statement of capital on 2015-11-12 GBP 10

See Also


Last update 2018

LARYNGOTECH LTD DIRECTORS

Helen Mary Harries

  Acting
Appointed
15 May 2011
Occupation
Secretary
Role
Director
Age
59
Nationality
British
Address
124 Rye House, 113 High Street, Ruislip, Middlesex, HA4 8JN
Country Of Residence
United Kingdom
Name
HARRIES, Helen Mary

Meredydd Lloyd Harries

  Acting PSC
Appointed
15 May 2011
Occupation
Doctor
Role
Director
Age
66
Nationality
British
Address
124 Rye House, 113 High Street, Ruislip, Middlesex, HA4 8JN
Country Of Residence
England
Name
HARRIES, Meredydd Lloyd
Notified On
6 June 2016
Nature Of Control
Ownership of shares – 75% or more

Peter Anthony Valaitis

  Resigned
Appointed
28 October 2008
Resigned
05 May 2011
Occupation
Manager
Role
Director
Age
74
Nationality
British
Address
Southfield House, 2 Southfield Road, Westbury On Trym, Bristol, Avon, BS9 3BH
Country Of Residence
United Kingdom
Name
VALAITIS, Peter Anthony

REVIEWS


Check The Company
Excellent according to the company’s financial health.